MedTrace Logo

Effects of Supradyn® Energy 3RDA on Fatigue/Stress, Substrate Metabolism During Exercise and Demanding Cognitive Tasks

NCT03003442 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2018-03-13

No results posted yet for this study

Summary

Investigation of the acute and chronic effects of Supradyn® Energy 3RDA on subjective ratings of 'fatigue/stress', substrate metabolism and blood biomarkers of recovery, as a consequence of exercise and metabolically demanding cognitive tasks.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Supradyn® Energy 3RDA

Multivitamin/mineral containing co-Q10

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Northumbria University

    lead OTHER

Principal Investigators

  • Crystal Haskell-Ramsay, Dr · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2017-10-16
Completion
2017-10-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03003442 on ClinicalTrials.gov